Literature DB >> 21340649

[Health services research the example of atopic dermatitis].

J Schmitt1.   

Abstract

Within the past years, health services research projects have analyzed critically the management of atopic eczema (AE) in routine care, quantified the utility of controlling severe AE, and introduced an international standardization of core outcome measures for AE. With a prevalence of 16%, AE is the most frequent chronic condition at all among children and adolescents seeking medical care. Despite lower prevalence in adults, about 60% of patients with AE in routine care are adults. There is a clinically relevant comorbidity of AE and psychiatric conditions. Independent of patient's age and physician's medical discipline topical corticosteroids dominate outpatient treatment of AE. However, there is considerable heterogeneity in the management of AE between treating physicians. Despite a lack of clinical trials, systemic corticosteroids are most frequently prescribed for severe AE. In contrast, cyclosporine only plays a minor role in routine care of severe AE although its efficacy is well-documented in trials. This observation stimulated a head-to-head trial that indicated superiority of cyclosporine over prednisolone for severe adult AE. The control of severe AE has high priority from the perspective of the general population and from the patients' perspective. Competence of the treating physician, disease severity and patient's competence to adjust treatment to disease activity are the main determinants of patient satisfaction. Aiming for a better comparability of clinical trials and better translation of trial evidence into clinical practice, we conducted a Delphi exercise including clinical experts from 11 countries, editors of international dermatological journals, regulatory agencies, and patient representatives. The preliminary core set of outcome domains for eczema trials as defined by the panel included symptoms, physician-assessed clinical signs, and a measurement for long-term control of flares. Symptoms such as itching should be regularly assessed in clinical practice. The presented studies indicate that health services research not only describes and critically analyzes the effectiveness of routine clinical care, but is also translational research in that it may stimulate clinical trials and generate new, clinically relevant hypotheses for experimental studies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21340649     DOI: 10.1007/s00105-010-2079-4

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  41 in total

1.  Atopic eczema and attention-deficit/hyperactivity disorder in a population-based sample of children and adolescents.

Authors:  Jochen Schmitt; Marcel Romanos; Natalie M Schmitt; Michael Meurer; Wilhelm Kirch
Journal:  JAMA       Date:  2009-02-18       Impact factor: 56.272

2.  Infant-onset eczema in relation to mental health problems at age 10 years: results from a prospective birth cohort study (German Infant Nutrition Intervention plus).

Authors:  Jochen Schmitt; Christian Apfelbacher; Chih-Mei Chen; Marcel Romanos; Stefanie Sausenthaler; Sibylle Koletzko; Carl-Peter Bauer; Ute Hoffmann; Ursula Krämer; Dietrich Berdel; Andrea von Berg; H-Erich Wichmann; Joachim Heinrich
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

3.  Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.

Authors:  Won Chan Lee; Sanjeev Balu; David Cobden; Ashish V Joshi; Chris L Pashos
Journal:  Clin Ther       Date:  2006-10       Impact factor: 3.393

Review 4.  Altered reactivity of the hypothalamus-pituitary-adrenal axis in patients with atopic dermatitis: pathologic factor or symptom?

Authors:  A Buske-Kirschbaum; S Jobst; D H Hellhammer
Journal:  Ann N Y Acad Sci       Date:  1998-05-01       Impact factor: 5.691

5.  Effects of the introduction of the German "Praxisgebühr" on outpatient care and treatment of patients with atopic eczema.

Authors:  Jochen Schmitt; Wilhelm Kirch; Michael Meurer
Journal:  J Dtsch Dermatol Ges       Date:  2009-10       Impact factor: 5.584

Review 6.  Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence.

Authors:  Karen Markussen Linnet; Søren Dalsgaard; Carsten Obel; Kirsten Wisborg; Tine Brink Henriksen; Alina Rodriguez; Arto Kotimaa; Irma Moilanen; Per Hove Thomsen; Jørn Olsen; Marjo-Riitta Jarvelin
Journal:  Am J Psychiatry       Date:  2003-06       Impact factor: 18.112

7.  Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trial.

Authors:  J Schmitt; K Schäkel; R Fölster-Holst; A Bauer; R Oertel; M Augustin; W Aberer; T Luger; M Meurer
Journal:  Br J Dermatol       Date:  2009-10-26       Impact factor: 9.302

Review 8.  What are the best outcome measurements for atopic eczema? A systematic review.

Authors:  Jochen Schmitt; Sinead Langan; Hywel C Williams
Journal:  J Allergy Clin Immunol       Date:  2007-10-01       Impact factor: 10.793

9.  Determinants of treatment goals and satisfaction of patients with atopic eczema.

Authors:  Jochen Schmitt; Friederike Csötönyi; Andrea Bauer; Michael Meurer
Journal:  J Dtsch Dermatol Ges       Date:  2008-01-08       Impact factor: 5.584

10.  OMERACT: an international initiative to improve outcome measurement in rheumatology.

Authors:  Peter Tugwell; Maarten Boers; Peter Brooks; Lee Simon; Vibeke Strand; Leanne Idzerda
Journal:  Trials       Date:  2007-11-26       Impact factor: 2.279

View more
  1 in total

1.  [Measurement of disease severity in dermatology].

Authors:  S Deckert; C Apfelbacher; J Schmitt
Journal:  Hautarzt       Date:  2015-09       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.